Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform to Outperform. Analyst Price Forecast Suggests 5.34% Downside As of ...

Masimo Corporation today announced its financial results for the first quarter ended March 29, 2025. GAAP revenue of $372 million, representing 10% on a reported basis; Non-GAAP revenue of $371 ...

Masimo today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. Masimo SET ® Measure-through Motion ...

IRVINE, Calif. -- (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 ...

IRVINE, Calif. -- (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 ...

IRVINE, Calif., October 29, 2024--Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring technology in the ED.

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable ...

Masimo Reports First Quarter 2025 Results Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 29, 2025.

IRVINE, Calif., April 02, 2025--Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2 ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...